Associated Papers
A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months.
Shimizu K et al.
Cold Spring Harbor Molecular Case Studies, 2022
Select a paper to view details